CELC Celcuity
- 17.230
- +0.340+2.01%
Celcuity News
Needham Reiterates Buy on Celcuity, Maintains $24 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $24 price target.
Celcuity Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 33.33% Needham → $24 Reiterates Buy → Buy 04/12/2024 33.33% Needham → $24 Reiterates Buy → Buy
Celcuity's Clinical and Financial Momentum Justifies Buy Rating and $24 Price Target
Growth Potential Drives Buy Rating for Celcuity Despite Current Losses
Celcuity (CELC) Surges After-Hours On Positive Financial Performance
After the closure of the market yesterday, Celcuity Inc. (NASDAQ: CELC) witnessed a significant uptick in its shares during the extended trading session. As per the latest update, CELC stock experienced a 4.70% increase, reaching $18.04 on the US stock market charts, following a 2.01% rise in the regular session, closing at $17.23. Strategic Milestones ...
Earnings Call Summary | Celcuity(CELC.US) Q1 2024 Earnings Conference
The following is a summary of the Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript:Financial Performance:Celcuity reported a Q1 2024 net loss of $21.6 million, an increase from its Q1 2023 net lo
Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA), Celcuity (CELC) and ATAI Life Sciences (ATAI)
Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
Celcuity Q1 Net Loss Widens; Shares Rise After Hours
Celcuity (CELC) reported a Q1 GAAP net loss late Wednesday of $0.64 per diluted share, compared with a loss of $0.55 a year earlier. Analysts polled by Capital IQ expected a loss of $0.70. No revenue
Celcuity | 10-Q: Quarterly report
Celcuity (CELC.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -0.59 dollars, previous value of -0.55 dollars, and expected value of -0.71 dollars.
Celcuity (CELC.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -0.59 dollars, previous value of -0.55 dollars, and expected value of -0.71 dollars.
Celcuity 1Q Loss/Shr 64c >CELC
Celcuity 1Q Loss/Shr 64c >CELC
Celcuity Q1 2024 Adj EPS $(0.59) Beats $(0.71) Estimate
Celcuity (NASDAQ:CELC) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.71) by 16.9 percent.
Celcuity Shareholders Approve Stock Plan Expansion and Elect Board
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...
Celcuity(CELC.US) Director Sells US$5,971 in Common Stock
$Celcuity(CELC.US)$ Director Buller Richard E sold 350 shares of common stock on Apr 24, 2024 at an average price of $17.06 for a total value of $5,971.Source: Announcement What is statement of change
Institutional Investors May Overlook Celcuity Inc.'s (NASDAQ:CELC) Recent US$51m Market Cap Drop as Long-term Gains Remain Positive
Key Insights Given the large stake in the stock by institutions, Celcuity's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 6 shareholders 14% of
Needham: Reiterates Celcuity (CELC.US) rating and adjusted from buy to buy rating, target price is $24.00.
Needham: Reiterates Celcuity (CELC.US) rating and adjusted from buy to buy rating, target price is $24.00.
Needham Reiterates Buy on Celcuity, Maintains $24 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $24 price target.
Analysis
Price Target
No Data
